George D. Yancopoulos - 10 Jun 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: Bd. Co-Chair, President & CSO, Director
Signature: By: Richard Gluckselig as attorney-in-fact For: George D. Yancopoulos
Issuer symbol: REGN
Transactions as of: 10 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 12 Jun 2024, 16:10:49 UTC
Previous filing: 17 May 2024
Next filing: 11 Dec 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Gift	$0	-75,799	-100%	$0.000000^*	0	10 Jun 2024	by 2022 GRAT II
transaction	REGN	Common Stock	Gift	$0	+37,900	+209%	$0.000000	56,048	10 Jun 2024	by Children
holding	REGN	Common Stock						868,994	10 Jun 2024	Direct
holding	REGN	Common Stock						5,903	10 Jun 2024	By 401(k) Plan
holding	REGN	Common Stock						180,000	10 Jun 2024	By Trust for Chldn.	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	As investment trustee of trusts for the benefit of the reporting person's children.